María‐Isabel Morosini

2.2k total citations
55 papers, 1.6k citations indexed

About

María‐Isabel Morosini is a scholar working on Molecular Medicine, Epidemiology and Pharmacology. According to data from OpenAlex, María‐Isabel Morosini has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Medicine, 17 papers in Epidemiology and 13 papers in Pharmacology. Recurrent topics in María‐Isabel Morosini's work include Antibiotic Resistance in Bacteria (39 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Pneumonia and Respiratory Infections (11 papers). María‐Isabel Morosini is often cited by papers focused on Antibiotic Resistance in Bacteria (39 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Pneumonia and Respiratory Infections (11 papers). María‐Isabel Morosini collaborates with scholars based in Spain, United Kingdom and Netherlands. María‐Isabel Morosini's co-authors include Rafael Cantón, Fernando Baquero, Jesús Blázquez, Rosa del Campo, María García-Castillo, Elena Loza, Marı́a-Cristina Negri, Teresa M. Coque, Patricia Ruíz-Garbajosa and Luís Máiz and has published in prestigious journals such as American Journal of Clinical Nutrition, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

María‐Isabel Morosini

54 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
María‐Isabel Morosini Spain 26 946 459 446 361 295 55 1.6k
Hervé Jacquier France 23 762 0.8× 515 1.1× 387 0.9× 378 1.0× 242 0.8× 68 1.7k
Thomas Guillard France 24 946 1.0× 313 0.7× 308 0.7× 394 1.1× 256 0.9× 77 1.4k
Christine Lascols France 25 1.2k 1.3× 297 0.6× 454 1.0× 544 1.5× 349 1.2× 44 2.1k
Yih‐Ru Shiau Taiwan 23 813 0.9× 401 0.9× 389 0.9× 371 1.0× 182 0.6× 32 1.5k
Jorge Luiz Mello Sampaio Brazil 25 1.1k 1.2× 475 1.0× 660 1.5× 579 1.6× 252 0.9× 82 2.1k
Jesús Silva-Sánchez Mexico 26 1.3k 1.4× 600 1.3× 224 0.5× 583 1.6× 229 0.8× 83 1.8k
Qinglan Guo China 23 1.3k 1.3× 319 0.7× 446 1.0× 476 1.3× 378 1.3× 57 1.6k
Eun-Jeong Yoon South Korea 25 1.5k 1.6× 682 1.5× 341 0.8× 554 1.5× 310 1.1× 59 2.0k
Fernando Docobo-Pérez Spain 25 1.1k 1.1× 331 0.7× 482 1.1× 327 0.9× 534 1.8× 65 1.5k
M Visalli United States 20 946 1.0× 370 0.8× 538 1.2× 254 0.7× 613 2.1× 32 1.6k

Countries citing papers authored by María‐Isabel Morosini

Since Specialization
Citations

This map shows the geographic impact of María‐Isabel Morosini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María‐Isabel Morosini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María‐Isabel Morosini more than expected).

Fields of papers citing papers by María‐Isabel Morosini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María‐Isabel Morosini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María‐Isabel Morosini. The network helps show where María‐Isabel Morosini may publish in the future.

Co-authorship network of co-authors of María‐Isabel Morosini

This figure shows the co-authorship network connecting the top 25 collaborators of María‐Isabel Morosini. A scholar is included among the top collaborators of María‐Isabel Morosini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María‐Isabel Morosini. María‐Isabel Morosini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avendaño‐Ortiz, José, Manuel Ponce‐Alonso, Emilio Llanos-González, et al.. (2023). The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification. Infection and Immunity. 91(2). e0001223–e0001223. 4 indexed citations
3.
García‐Fernández, Sergio, Manuel Ponce‐Alonso, Ana María Sánchez‐Díaz, et al.. (2021). Etiology and antimicrobial susceptibility profiles of anaerobic bacteria isolated from clinical samples in a university hospital in Madrid, Spain. Anaerobe. 72. 102446–102446. 7 indexed citations
4.
Diez‐Aguilar, María, Miquel B. Ekkelenkamp, María‐Isabel Morosini, et al.. (2021). Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates. Journal of Antimicrobial Chemotherapy. 76(10). 2578–2585. 19 indexed citations
5.
Morosini, María‐Isabel, María Diez‐Aguilar, & Rafael Cantón. (2019). Mechanisms of action and antimicrobial activity of ceftobiprole.. PubMed. 32 Suppl 3. 3–10. 30 indexed citations
6.
Francisco, Carolina Navarro-San, et al.. (2019). Direct antimicrobial susceptibility testing from the blood culture pellet obtained for MALDI-TOF identification of Enterobacterales and Pseudomonas aeruginosa. European Journal of Clinical Microbiology & Infectious Diseases. 38(6). 1095–1104. 9 indexed citations
7.
García‐Fernández, Sergio, Matthias Steglich, Aitor Gonzaga, et al.. (2019). Whole-genome sequencing reveals nosocomial Clostridioides difficile transmission and a previously unsuspected epidemic scenario. Scientific Reports. 9(1). 6959–6959. 22 indexed citations
8.
Diez‐Aguilar, María, Miquel B. Ekkelenkamp, María‐Isabel Morosini, et al.. (2018). Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients. International Journal of Antimicrobial Agents. 53(1). 84–88. 29 indexed citations
9.
García‐Fernández, Sergio, María‐Isabel Morosini, Desirée Gijón, et al.. (2015). Detection of Carbapenemase Production in a Collection of Enterobacteriaceae with Characterized Resistance Mechanisms from Clinical and Environmental Origins by Use of Both Carba NP and Blue-Carba Tests. Journal of Clinical Microbiology. 54(2). 464–466. 17 indexed citations
10.
Fernández-Olmos, A., María García-Castillo, María‐Isabel Morosini, et al.. (2011). MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients. Journal of Cystic Fibrosis. 11(1). 59–62. 77 indexed citations
11.
García-Castillo, María, Rosa del Campo, Fernando Baquero, et al.. (2010). Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients. Clinical Microbiology and Infection. 17(5). 704–711. 12 indexed citations
12.
Cobo, Javier, María‐Isabel Morosini, & Rafael Cantón. (2008). Commentary on manuscript: Tigecycline for treating bloodstream infections: a critical analysis of the available evidence. Diagnostic Microbiology and Infectious Disease. 61(3). 360–361. 1 indexed citations
13.
Cantón, Rafael, et al.. (2008). IRT and CMT β-lactamases and inhibitor resistance. Clinical Microbiology and Infection. 14. 53–62. 88 indexed citations
14.
García-Castillo, María, et al.. (2008). Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates. Journal of Antimicrobial Chemotherapy. 62(5). 1027–1030. 52 indexed citations
15.
Cantón, Rafael, Juan-Ignacio Alós, Fernando Baquero, et al.. (2007). Recomendaciones para la selección de antimicrobianos en el estudio de la sensibilidad in vitro con sistemas automáticos y semiautomáticos. Enfermedades Infecciosas y Microbiología Clínica. 25(6). 394–400. 13 indexed citations
16.
Cobo, Javier, María‐Isabel Morosini, Vicente Pintado, et al.. (2007). Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 β-lactamase–producing Klebsiella pneumoniae epidemic clone. Diagnostic Microbiology and Infectious Disease. 60(3). 319–322. 43 indexed citations
17.
Morosini, María‐Isabel, María García-Castillo, Teresa M. Coque, et al.. (2006). Antibiotic Coresistance in Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae and In Vitro Activity of Tigecycline. Antimicrobial Agents and Chemotherapy. 50(8). 2695–2699. 130 indexed citations
18.
Cantón, Rafael, Annarita Mazzariol, María‐Isabel Morosini, Fernando Baquero, & Giuseppe Cornaglia. (2005). Telithromycin activity is reduced by efflux in Streptococcus pyogenes. Journal of Antimicrobial Chemotherapy. 55(4). 489–495. 17 indexed citations
19.
Morosini, María‐Isabel, Rafael Cantón, Elena Loza, et al.. (2001). In Vitro Activity of Telithromycin against Spanish Streptococcus pneumoniae Isolates with Characterized Macrolide Resistance Mechanisms. Antimicrobial Agents and Chemotherapy. 45(9). 2427–2431. 39 indexed citations
20.
Negri, M. C., María‐Isabel Morosini, Jesús Blázquez, & Fernando Baquero. (2000). Antibiotic resistance in hospital infections: the role of newer cephalosporins. Clinical Microbiology and Infection. 6. 95–97. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026